Research Analysts’ Weekly Ratings Changes for Nexxen International (NEXN)
by Teresa Graham · The Cerbat GemNexxen International (NASDAQ: NEXN) has recently received a number of price target changes and ratings updates:
- 11/14/2025 – Nexxen International had its price target lowered by analysts at Canaccord Genuity Group Inc. from $14.00 to $12.00. They now have a “buy” rating on the stock.
- 11/14/2025 – Nexxen International had its price target lowered by analysts at Royal Bank Of Canada from $14.00 to $12.00. They now have an “outperform” rating on the stock.
- 11/14/2025 – Nexxen International had its price target lowered by analysts at Citizens Jmp from $15.00 to $12.00. They now have a “market outperform” rating on the stock.
- 11/13/2025 – Nexxen International had its price target lowered by analysts at BTIG Research from $13.00 to $10.00. They now have a “buy” rating on the stock.
- 11/13/2025 – Nexxen International was downgraded by analysts at Craig Hallum from a “buy” rating to a “hold” rating. They now have a $8.00 price target on the stock.
- 11/13/2025 – Nexxen International had its price target lowered by analysts at Needham & Company LLC from $14.00 to $9.00. They now have a “buy” rating on the stock.
- 10/8/2025 – Nexxen International had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
- 10/7/2025 – Nexxen International is now covered by analysts at BTIG Research. They set a “buy” rating and a $13.00 price target on the stock.
- 10/6/2025 – Nexxen International was upgraded by analysts at BTIG Research to a “strong-buy” rating.
Tremor International Ltd provides end-to-end software platform that enables advertisers to reach relevant audiences and publishers. The company's demand side platform (DSP) offers full-service and self-managed marketplace access to advertisers and agencies to execute their digital marketing campaigns in real time across various ad formats.
Featured Stories
- Five stocks we like better than Nexxen International
- Conference Calls and Individual Investors
- Wall Street Punished CrowdStrike for Beating Earnings? Seriously?
- 3 Healthcare Dividend Stocks to Buy
- Okta: Excuses to Sell Vs. Reasons to Buy
- Insider Trades May Not Tell You What You Think
- NASA Calls, Plug Answers: A Turning Point for Hydrogen?